Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.84M Buy
21,179
+321
+2% +$90.7K 0.47% 61
2026
Q1
$5.56M Buy
20,858
+577
+3% +$160K 0.47% 58
2025
Q4
$5.58M Sell
20,281
-305
-1% -$85.5K 0.49% 60
2025
Q3
$5.93M Buy
20,586
+433
+2% +$128K 0.55% 49
2025
Q2
$6.66M Buy
20,153
+511
+3% +$165K 0.73% 32
2025
Q1
$6.46M Buy
19,642
+454
+2% +$137K 0.68% 37
2024
Q4
$5.3M Buy
19,188
+2,855
+17% +$910K 0.62% 42
2024
Q3
$5.66M Sell
16,333
-76
-0.5% -$26.2K 0.56% 45
2024
Q2
$5.42M Sell
16,409
-514
-3% -$177K 0.64% 40
2024
Q1
$6.15M Sell
16,923
-247
-1% -$81.3K 0.84% 36
2023
Q4
$5.14M Buy
+17,170
New +$5.02M 0.78% 33

Other funds holding CI

Oxbow Advisors's CI Position: Q2 2026 in Review

Oxbow Advisors increased its Cigna (CI) stake by 1.5% in Q2 2026, buying an estimated $90.7K and bringing the position to 21,179 shares worth $5.84M. The position accounts for 0.47% of the portfolio, ranked #61.

Oxbow Advisors first reported a position in CI in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.66M in Q2 2025. 1,700 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Oxbow Advisors held 21,179 shares of Cigna worth $5.84M as of Q2 2026.
  • Oxbow Advisors bought 321 Cigna shares in Q2 2026, an estimated $90.7K.
  • Cigna made up 0.47% of Oxbow Advisors's portfolio in Q2 2026, its #61 holding.
  • Oxbow Advisors first reported a position in Cigna in Q4 2023 and has held it in 11 quarters since.
  • Oxbow Advisors's Cigna position peaked at $6.66M in Q2 2025.
  • 1,700 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Oxbow Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.